Outcomes and relapse patterns of stage IB grade 2 or 3 endometrial cancer treated with adjuvant vaginal brachytherapy.
Alexandra HochreiterJacqueline R KellyMelissa Rasar YoungBabak LitkouhiJonathan David BlackCarmen StrombergerSusan HigginsPeter E SchwartzShari DamastPublished in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2019)
Among patients with stage IB grade 2-3 endometrial cancer treated with vaginal brachytherapy, the risk factors for recurrence (larger tumor size and lower uterine segment involvement) in conjunction with established risk factors (high grade, ≥50% myometrial invasion, and lymphovascular invasion) may identify a group of high-risk patients who might benefit from pelvic radiotherapy.